Distinguished in Streptococcal Group B Infection

Clare L. Cutland

Johannesburg, GT, ZA 
Distinguished in Streptococcal Group B Infection
Johannesburg, GT, ZA 
OverviewLocationsClinical Research

Overview

Clare Cutland practices in Johannesburg, South Africa. Ms. Cutland is rated as a Distinguished expert by MediFind in the treatment of Streptococcal Group B Infection. Her top areas of expertise are Streptococcal Group B Infection, Strep Throat, Tetanus, and Flu.

Her clinical research consists of co-authoring 152 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 36 articles and participated in 2 clinical trials in the study of Streptococcal Group B Infection.

Gender
Female

Locations

Johannesburg, GT, South Africa
Other Locations
Groote Schuur Hospital And The University Of Cape Town, Cape Town, WC, South Africa
South Africa, WC, South Africa
South Africa
Soweto, GT, South Africa

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Group B Streptococcus (GBS) Associated Stillbirths in a High Burden Setting
Group B Streptococcus (GBS) Associated Stillbirths in a High Burden Setting
Enrollment Status: Completed
Publish Date: May 28, 2024
An Open-labeled, Randomized Controlled Trial Evaluating for Non-inferiority of 1+1 Compared to 2+1 Dosing Schedules of 10-valent and 13-valent Pneumococcal Conjugate Vaccine (PCV) in South African Children
An Open-labeled, Randomized Controlled Trial Evaluating for Non-inferiority of 1+1 Compared to 2+1 Dosing Schedules of 10-valent and 13-valent Pneumococcal Conjugate Vaccine (PCV) in South African Children
Enrollment Status: Completed
Publish Date: December 09, 2019
Intervention Type: Biological
Study Phase: Phase 3
Establishing a Sero-correlate of Protection Against Invasive Group B Streptococcus Disease in Newborns and Young Infants Aged <=90 Days
Establishing a Sero-correlate of Protection Against Invasive Group B Streptococcus Disease in Newborns and Young Infants Aged <=90 Days
Enrollment Status: Completed
Publish Date: September 13, 2018
Effect of HIV and/or Active Tuberculosis on the Humoral and Cell Mediated Immune Responses to Un-adjuvanted Trivalent Sub-unit Influenza Vaccine (TIV) in Adults
Effect of HIV and/or Active Tuberculosis on the Humoral and Cell Mediated Immune Responses to Un-adjuvanted Trivalent Sub-unit Influenza Vaccine (TIV) in Adults
Enrollment Status: Completed
Publish Date: September 05, 2018
Intervention Type: Biological
Study Phase: Phase 4
View 3 Less Clinical Trials

152 Total Publications

Corrigendum to "Defining and reporting adverse events of special interest in comparative maternal vaccine studies: a systematic review". [Vaccine X, 2024 Feb 23;18:100464].
Corrigendum to "Defining and reporting adverse events of special interest in comparative maternal vaccine studies: a systematic review". [Vaccine X, 2024 Feb 23;18:100464].
Journal: Vaccine: X
Published: August 14, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Cutland's expertise for a condition
ConditionClose
    View All 26 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile